Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

Specimen Handling 146 pembrolizumab 120 Magnetic Resonance Spectroscopy 117 Cyclophosphamide 114 Biopsy 97 fludarabine 88 Nivolumab 52 Carboplatin 51 Cisplatin 47 Gemcitabine 46 venetoclax 41 Radiotherapy 41 Paclitaxel 40 Cetuximab 40 fludarabine phosphate 39 Ipilimumab 34 atezolizumab 33 Fluorouracil 33 Bevacizumab 33 Oxaliplatin 27 Leucovorin 27 Dexamethasone 27 durvalumab 26 X-Rays 25 Irinotecan 25 Radiation 24 Cytarabine 24 Azacitidine 24 Injections 22 Temozolomide 21

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Cell Count × 90 days × Clear all

NCT05887882 2026-04-24

PNOC028

University of California, San Francisco

Phase 1 Suspended

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡